최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of ethnopharmacology, v.195, 2017년, pp.204 - 213
Yoon, S. , Kim, J. , Lee, H. , Lee, H. , Lim, J. , Yang, H. , Shin, S.S. , Yoon, M.
Conclusions: These results suggest that GGH(4) inhibits obesity-induced hepatic steatosis and that this process may be mediated by regulation of the expression of PPAR alpha target genes and lipogenic genes. GGH(4) also suppressed obesity-related hepatic inflammation. Thus, GGH(4) may be a promising...
N. Engl. J. Med. Angulo 346 1221 2002 10.1056/NEJMra011775 Nonalcoholic fatty liver disease
Nat. Med. Cai 11 183 2005 10.1038/nm1166 Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB
Clin. Gastroenterol. Hepatol. Charlton 2 1048 2004 10.1016/S1542-3565(04)00440-9 Nonalcoholic fatty liver disease: a review of current understanding and future impact
Hepatology Chatzigeorgiou 60 1196 2014 10.1002/hep.27233 Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation
Mol. Interv. Das 6 36 2006 10.1124/mi.6.1.7 Resveratrol in cardioprotection: a therapeutic promise of alternative medicine
Gastroenterology Day 114 842 1998 10.1016/S0016-5085(98)70599-2 Steatohepatitis: a tale of two “hits”?
J. Clin. Invest. Donnelly 115 1343 2005 10.1172/JCI23621 Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
QJM Dowman 103 71 2010 10.1093/qjmed/hcp158 Pathogenesis of non-alcoholic fatty liver disease
Hepatology Fabbrini 51 679 2010 10.1002/hep.23280 Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Heo, J., 2004. The Dongui Bogam, Namsandang, Seoul, Korea.
J. Clin. Invest. Horton 101 2331 1998 10.1172/JCI2961 Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2
10.1007/BF01070758 Hoyumpa, A.M. Jr., Greene, H.L., Dunn, G.D., Schenker, S., 1975. Fatty liver: biochemical and clinical considerations. Am. J. Dig. Dis. 20, 1142-1170.
Hepatology Ip 38 123 2003 10.1053/jhep.2003.50307 Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice
Hepatology Ip 39 1286 2004 10.1002/hep.20170 Administration of the potent PPARalpha agonist, Wy-14.643, reverses nutritional fibrosis and steatohepatitis in mice
J. Agric. Food Chem. Jayaprakasha 50 3668 2002 10.1021/jf025506a Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin
Metabolism Jeong 53 607 2004 10.1016/j.metabol.2003.12.010 Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice
Exp. Mol. Med. Jeong 41 397 2009 10.3858/emm.2009.41.6.045 Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice
J. Ethnopharmacol. Jeong 119 245 2008 10.1016/j.jep.2008.06.037 The Korean traditional medicine Gyeongshingangjeehwan inhibits obesity through the regulation of leptin and PPARalpha action in OLETF rats
Diabetes Kawano 41 1422 1992 10.2337/diab.41.11.1422 Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain
Hepatology Kleiner 41 1313 2005 10.1002/hep.20701 Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease
J. Chem. Pharm. Res. Ko 7 234 2015 Oregonin from the stems and leaves of Korean Alnus species (Betulaceae)
Eur. J. Pharmacol. Kurita 588 316 2008 10.1016/j.ejphar.2008.04.028 Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects
Korean Soc. Orient. Pathol. Lee 27 99 2013 Gambigyeongsinhwan (4) reduces body weight and hepatic lipid accumulation in high fat diet-fed obese male C57BL/6N mice
Lee 1996 Korean Folk Medicine
Li 2006 LI Dong Yuan Medical Encyclopedia
Hepatology Marchesini 37 917 2003 10.1053/jhep.2003.50161 Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
Dev. Psychobiol. Moran 48 360 2006 10.1002/dev.20149 Hyperphagia and obesity of OLETF rats lacking CCK1 receptors: developmental aspects
Prog. Lipid Res. Musso 48 1 2009 10.1016/j.plipres.2008.08.001 Recent insights into hepatic lipid metabolism in nonalcoholic fatty liver disease (NAFLD)
Toxicology Ozer 245 194 2008 10.1016/j.tox.2007.11.021 The current state of serum biomarkers of hepatotoxicity
Korean J. Orient. Med. Paik 33 33 2012 The effects in metabolism and adipose tissue imflammation induced by the Massa Medica Fermentata on obese type 2 diabetes mouse model
Gastroenterology Parekh 132 2191 2007 10.1053/j.gastro.2007.03.055 Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease
Br. J. Nutr. Parks 87 S247 2002 10.1079/BJN/2002544 Dietary carbohydrate's effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations
Clin. Sci. Preiss 115 141 2008 10.1042/CS20070402 Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations
Am. J. Physiol. Gastrointest. Liver. Physiol. Reddy 290 G852 2006 10.1152/ajpgi.00521.2005 Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation
J. Ethnopharmacol. Roh 171 287 2015 10.1016/j.jep.2015.05.056 Herbal composition Gambigyeongsinhwan (4) from Curcuma longa, Alnus japonica, and Massa Medicata Fermentata inhibits lipid accumulation in 3T3-L1 cells and regulates obesity in Otsuka LongEvans Tokushima fatty rats
J. Altern. Complement. Med. Sharpe 13 217 2007 10.1089/acm.2006.6129 Use of complementary and alternative medicine for weight control in the United States
J. Clin. Invest. Shimano 99 846 1997 10.1172/JCI119248 Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells
J. Ethnopharmacol. Shin 127 47 2010 10.1016/j.jep.2009.09.052 The Korean traditional medicine gyeongshingangjeehwan inhibits adipocyte hypertrophy and visceral adipose tissue accumulation by activating PPARalpha actions in rat white adipose tissues
Pharm. Biol. Shin 50 1261 2012 10.3109/13880209.2012.666982 The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits high-fat diet-induced hepatic steatosis via hepatic PPARα activation
N. Engl. J. Med. Shulman 353 604 2005 10.1056/NEJMra043590 Retinoid X receptor heterodimers in the metabolic syndrome
Gene Takiguchi 197 169 1997 10.1016/S0378-1119(97)00259-X Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats
Trends Endocrinol. Metab. Tilg 19 371 2008 10.1016/j.tem.2008.08.005 Insulin resistance, inflammation, and non-alcoholic fatty liver disease
Basic. Clin. Pharmacol. Toxicol. Um 3 152 2013 10.1111/bcpt.12076 Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase
Methods Find. Exp. Clin. Pharmacol. Valcheva-Kuzmanova 29 101 2007 10.1358/mf.2007.29.2.1075349 Hypoglycemic and hypolipidemic effects of Aronia melanocarpa fruit juice in streptozotocin-induced diabetic rats
Hepatology Vuppalanchi 49 306 2009 10.1002/hep.22603 Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management
Hepatology Yamaguchi 45 1366 2007 10.1002/hep.21655 Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Curr. Diabetes Rep. Yki-Jarvinen 7 173 2007 10.1007/s11892-007-0028-0 ADOPT: Lessons from comparison of glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Pharmacol. Res. Yoon 60 151 2009 10.1016/j.phrs.2009.02.004 The role of PPARα in lipid metabolism and obesity: focusing on the effects of estrogen on PPARα actions
PPAR Res. Yoon 2010 584296. 2010 10.1155/2010/584296 PPARα in obesity: sex difference and estrogen involvement
Yakhak Hoeji Zhao 56 99 2012 Hepatoprotective effects of Alnus japonica extract on experimental liver injury model
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.